We are devoted to making novel discoveries that lead to new strategies for disease treatment and prevention and to translating them into clinical trials that deliver the most effective treatments to our patients. Our cancer experts also are available to provide second opinions and original work. MD , Full Professor of Medical Oncology. Access MyChart Overview Education Bio Locations Medical Services Lung Cancer Services Medical Oncology Services Our infusion centers in Orange, Costa Mesa,Yorba Lindaand Laguna Hillsprovide the most advanced and personalized care to patients undergoing chemotherapy. The EAB reviews the overall strategy and progress and makes specific recommendations to the CFCCC director to improve our goals under our mission. Division of Hematology/Oncology - University of California, Irvine Clinical Professor, Division of Hematology/Oncology, Medicine School of Medicine Associate Director for Clinical Sciences, Chao Family Comprehensive Cancer Center M.D., Chicago Medical School, 1986, Medicine B.S., University of Southern California, 1981, Psychobiology Phone: (714) 456-5153 Fax: (714) 456-2242 Email: wachow@uci.edu "Most cancers are diagnosed too late," he says. After more than a decade of work helping patients like Allen Fremont, Dr. Sai-hong Ignatius Ou has gained FDA approval for a drug treatment that targets mutations of non-small cell lung cancers. in Orange County, which means that patients with leukemia, lymphoma and other cancers no longer need to travel long distances for this life-saving treatment. Assistant/ Associate/ Full Professor In Residence (Hematology/Oncology Irvine, and Master of Science in Global Medicine at the University of Southern California's Keck School of Medicine before completing my medical education at Des Moines University. UCI is seeking a dynamic leader with strong credentials in clinical medicine and basic, translational, or clinical research. The University of California, Irvine, School of Medicine, Department of Medicine, Division of Hematology/Oncology is seeking a dynamic leader with strong credentials in clinical medicine and basic, translational, or clinical research for the position of Hematology/Oncology Division Chief. We are participating in a National Cancer Institute clinical trial to determine whether COVID-19 affects therapies in cancer patients who acquire the virus. Appointment as Clinical Staff Investigator within the Chao Family Comprehensive Cancer Center [P30 Cancer Center Support Grant] April 2019- present (one of only two positions at UCI) 16. Department of Medicine > Division of Hematology/Oncology > Faculty Faculty Edward L. Nelson, MD Division Chief Pamela S. Becker, MD Elizabeth Brm, MD May T. Cho, MD Warren A. Chow, MD Stefan O. Ciurea, MD Director, Hematopoetic Stem Cell Transplantation and Cellular Therapy Program Paul H. Coluzzi, MD Farshid Dayyani, MD, PhD Michelle Clark-Salib fought cancer and delivered a healthy son, COVID-19 vaccine and protecting your health , National Cancer Institute-designated comprehensive cancer center in Orange County, only adult hematopoietic stem-cell transplant services, Our cancer experts also are available to provide second opinions , Hematology-Oncology Services (Leukemia, Lymphoma and Myeloma), Quality OncologyPractice Initiative (QOPI) CertificationProgram, Blue Distinction Center for Complex and Rare Cancers, Learn more about our Blue Distinction Center designation , 53 National Cancer Institute (NCI)-designated comprehensive cancer centers, HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, Stem cell transplant wards off aggressive lymphoma, Dedicated to cancer research & treatment (video), OCMA honors UCI Health 'Physicians of Excellence', 2022 UCI Anti-Cancer Challenge raises record $1 million for promising cancer research, UCI Health honored for surgical safety and excellence, UCI opens first natural killer cell clinical trial for recurrent glioblastoma, $8 million grant expands access to UCI stem cell clinical trials, Gastric cancer patient gets new lease on life, Riding tall a decade after prostate surgery, A novel approach to advanced stomach cancer, Take a virtual tour of the infusion center at UCI Health Cancer Center Newport , Integrate innovative research with the most advanced diagnostics, treatments, rehabilitation and, Offer one of the largest early-phase clinical trials programs in Southern California, giving our patients access to promising therapies before they are available elsewhere. Diversity is core to our ability to offer compassionate and culturally competent care in a variety of practice settings, to patients from all walks of life, addressing simple to complex healthcare needs, while working with others who embrace a broad variety of backgrounds, experience, and perspectives. The infusion center at the UCI Health Cancer Center Newport, in particular, was designed to provide a tranquil, healing environment. Posted 9:46:56 PM. The NCI designation also means that doctors are focused not only on treating and curing cancer but on cancer prevention and early detection, notes Dr. Richard Van Etten, director of the Chao Center and a professor of medicine in the Division of Hematology/Oncology. The fellowship program is designed to educate and support future clinical investigators who plan to dedicate their professional careers to clinical or laboratory research in hematology and oncology. COVID-19 vaccine and protecting your health , UCI Health Chao Family Comprehensive Cancer Center in Orange, Professor Division of Hematology/Oncology, Department of Medicine, UCI School of Medicine, Director UCI Health Hematopoietic Stem Cell Transplant and Cellular Therapy Program. Medical Education. He sees patients at the UCI Health Chao Family Comprehensive Cancer Center in Orange. Through participation in clinical trials, patients at UCI Health can gain access to new therapies long before they become available to the general public. He completed an internal medicine residency at UPMC Pinnacle Harrisburg in Harrisburg, Pa. Contact Us Division of Hematology/Oncology Department of Medicine UCI School of Medicine 101 The City Drive South, Building 56, ZOT 4061 Orange, CA 92868 MAP Business office: 714-456-5153 Business fax: 714-456-2242 For clinical services and appointments, please call 714-456-8000 or fax to 714-456-7142. Management of Metastatic Colorectal Cancer in the Community-Based Setting. She was so ccompationate and made me feel . They also are encouraged to attend the 12 different disease specific tumor boards that are conducted on a weekly basis. Join to apply for the Assistant Professor In Residence (Hematology/Oncology) with emphasis on Cancer Epidemiology role at UC Irvine First name Last name Email Password (8+ characters) By. We have one of the largest early-phase clinical research programs in Southern California, giving patients access to promising experimental medicines in the very earliest studies. UC Irvine - Faculty Profile System - Nataliya Mar MD UCI Health hematologic oncologists provide consultation and treatment for patients with many different types of cancer, These include including malignancies of the blood such as leukemia, lymphoma and myeloma, as well as solid tumor carcinomas such as colon, breast and prostate. Fellows receive three weeks vacation per year. Use MyChart to schedule appointments, request prescription renewals, send messages to your care team and more. Tiffany Chao, MD. Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine; Assistant/ Associate/ Full Professor In Residence (Hematology/Oncology) UC Irvine Irvine, CA. CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP) UCI School of Medicine . Cancer patients at UCI Health benefit from an individualized treatment plan tailored to their specific condition. We strive to provide the best possible care, tailored for each patient's individual needs. 2023 The Regents of the University of California. Clinical trials often compare the most accepted cancer treatments with new treatments that our physicians and researchers hope will be more effective. . Malignant blood diseases such as acute and chronic leukemia, lymphoma, myeloma and other bone marrow disorders often involve a complex treatment plan. UC Irvine School of Medicine epidemiology and hematology researchers At the UCI Chao Family Comprehensive Cancer Center, we work to prevent, manage, and cure cancer so all people live healthier, longer lives. Division of Hematology/Oncology. . This button displays the currently selected search type. . See Professorial Series (Adjunct, Clinical X, HS Clinical, In Residence, Ladder Rank) and Professor of Teaching Series Division of Hematology/Oncology - University of California, Irvine Division of Hematology/Oncology - University of California, Irvine He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston. Assistant Professor In Residence (Hematology/Oncology) with emphasis on UC Irvine hiring Director, Early Phase Clinical Trials and Precision Chapter 21. We also are passionate about fostering these discoveries within the context of a dynamic environment that is focused on developing top-caliber physician and scientists. bone marrow transplantation, chimeric antigen receptor (CAR) T-cell therapy, natural killer cell therapy. Our physicians participate in National Cancer Institute-sponsored clinical trials featuring new drugs and the most advanced options in treatment and care. During the inpatient clinical experience fellows provide care and consultative services to a varied population of patients. The oncology division provides comprehensive care for children with childhood cancers such leukemia and solid tumors. All rights reserved. . One each from columns A and B. When expanded it provides a list of search options that will switch the search inputs to match the current selection. Nov 21, 2022, 2:52 PM UTC duke and rhonda thorson hess clinic southampton county dump schedule gmail filter from domain 7 12 sani for makara rasi 2022 retro vintage sexy girls. Christine and Gordon McLarens research is advancing the prognosis for a hereditary blood-iron overload disorder. Chief, Division of Hematology/Oncology Melanie Funes, PhD Chief Administrative Officer Associate Director, Administration & Finance Senior Leadership Council Allen Chen, MD Professor and Chair, Department of Radiation Oncology Maheswari "Magi" Senthil, MD Medical Director of Oncology Services Our UCI Health hematologists and hematological oncologists include: Sign up for our monthly e-newsletter and get the latest health tips and stories from our Live Well blog . We are engaged in basic and translational cancer research to better understand cancer and blood diseases and also to use the best, leading-edge clinical approaches for our patients. The amount of user location information collected and applied has increased, and if these datasets are directly released, attackers may infer other unknown locations through partial background knowledge in their possession. The Divisions of Hematology and Oncology are committed to the delivery of exemplary clinical care, to advancing research and to training future healthcare professionals. The UC Hematologic Malignancies & Bone Marrow Transplant Center offers the most advanced care in the region for adults with cancers of the blood. During the second half of the first year fellows begin exploring research options around their individual interests. Dr. Sender, medical director of the oncology services team at the Chao Family Comprehensive Cancer Center, is a nationally known expert in disorders of the blood and lymphatic system. Here at UCI Department of Medicine, we highly value diversity. Giuseppe ALTAVILLA | MD , Full Professor of Medical Oncology UC Irvine - Faculty Profile System - Justin Tyler Moyers MD I am so glad I picked the right Oncologist. The fellowship has a 100% ABIM board pass rate in Medical Oncology and a 92% ABIM Board pass rate in Hematology over the past five year period. Some of our clinical research is focused on prevention of breast, colon, esophageal, liver, pancreatic and prostate cancers, in both phase 2 and phase 3 clinical trials, as well as phase 1 trials. During and after treatment, our cancer center dietitians, social workers and rehabilitation therapists work closely with you to support your recovery. For cancer treatment to be effective, we believe treatment must be unique and personalized for each patient. Select two study versions to compare. No cancer is rare to us. Apply Join or sign in to find your next job. In addition, the division pays for each fellow to attend an educational conference every year and allows for educational time to attend conferences. Irvine, Calif., Nov. 12, 2014 Researchers at the UC Irvine School of Medicine have received a $2.04 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study genetic modifiers of iron status in hemochromatosis, a hereditary disease in which affected persons suffer excessive dietary iron absorption. Experience being involved in non-cancer therapeutics development in addition to the cancer experience is a plus The porcine epidemic diarrhea virus, PEDV, which causes diarrhea, vomiting and death in piglets, causes huge economic losses. The hematology division provides diagnostic, therapeutic and consultative care to children with hematologic disorders such as hemophilia, anemia and platelet disorders. Beating Cancer - One Patient at a Time | UCI News | UCI http://www.avensonline.org/fulltextarticles/jun-2380-0585-02-0009.html, Obstructive Jaundice as Initial Presentation of Multiple Myeloma: Case Presentation and Literature Review, https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26221143/, I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib, https://www.sciencedirect.com/science/article/pii/S0169500215000938?via%3Dihub, Pancytopenia in a patient with cystinosis secondary to myelosuppression from cystine crystal deposition: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573917/, Patients' preferences for biopsy result notification in an era of electronic messaging methods, https://jamanetwork.com/journals/jamadermatology/fullarticle/2212245, Assessing Bacterial Isolates in Bloodstream Infections and Trend of the Antimicrobial Resistance in the Hematological and Solid Malignancies, http://www.bloodjournal.org/content/126/23/5628/tab-article-info, Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254519/, Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139287/, The case of the missed physical examination: testicular carcinoma presenting as a GI bleed, http://ascopubs.org/doi/abs/10.1200/JCO.2012.45.2680?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed, Mortality risk after preoperative versus postoperative chemotherapy and radiotherapy in lymph node-positive rectal cancer, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551443/, Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593948/, Heart rate decrease during crizotinib treatment and potential correlation to clinical response, Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593561/, Excessive therapeutic response in a case of blastic plasmacytoid dendritic cell neoplasm, Population-based evaluation of adenosquamous carcinoma of the colon and rectum, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330249/, Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy, https://www.futuremedicine.com/doi/full/10.2217/fon.12.25?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&, Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443348/, New mechanistic explanation for the localization of ulcers in the rat duodenum: Role of iron and selective uptake of cysteamine, https://www.sciencedirect.com/science/article/pii/S0003986112002135?via%3Dihub, Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516190/, Risk of second primary colorectal cancer among colorectal cancer cases: a population-based analysis, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072650/, Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer, https://insights.ovid.com/pubmed?pmid=21471752, Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202168/, Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140277/, Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017764/, Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles, https://www.spandidos-publications.com/ijmm/26/1/121, Target of rapamycin signaling in leukemia and lymphoma, http://clincancerres.aacrjournals.org/content/16/22/5374.long, Board-certification or board-eligibility in internal medicine, Proof of medical school graduation (original diploma), Proof of passing the three-step United States Medical Licensing Examination (USMLE), U.S. citizenship, permanent residency, or J-1 visa with ECFMG sponsorship. The activities of atRA are mediated by nuclear RA receptors (RARs) to alter gene expression (canonical activities) or by cellular retinoic acid binding protein 1 (CRABP1) to rapidly (minutes) modulate cytosolic kinase signaling, including calcium calmodulin-activated . Hematology/Oncology Fellowship - University of California, Irvine Our faculty members are subspecialty-trained, board-certified hematologists and oncologists who care for inpatients at UCI Medical Center and outpatients at Chao Family Comprehensive Cancer Center, which is the only National Cancer Institute-designated comprehensive cancer center in Orange County and one of only 50 in the nation. Methods: This was a retrospective study of patients in the California Cancer Registry aged 18 to 79 years with recent diagnoses of anal squamous cell carcinoma. They work together with other cancer center specialists todiagnose, evaluate and treat all malignant disorders. Specialties: We are UCI Health: A devoted team of nationally regarded physicians and nurses, researchers and clinicians, educators and students united by a single calling to improve the lives of the people in our community and beyond. JCM | Free Full-Text | Is There an Association between Concurrent For questions about the application process, go to ERAS online or call 215.966.3940. (PDF) Population-Based Analysis of National Comprehensive Cancer Join to apply for the . Throughout fellowship hematology/oncology fellows function as primary longitudinal caregivers to a panel of patients and serve as consultants directing the management of large numbers of patients under the supervision and guidance of faculty physicians. During the second and/or third year fellows develop and participate in a longitudinal research project spanning 18 months of protected time under the supervision of research mentor. Divisions of Pediatric Hematology and Oncology | Department of Dr. Monica El-Masry is a hematologist and medical oncologist who practices in Porter Ranch and at the Veteran's Affairs Medical Center. A disability plan is available through the Irvine House Staff Association. Learn more about our research and clinical trials . Irvine, CA . Our modern infusion center allows our patients to undergo chemotherapy in privacy and comfort, attended by our team of experienced and compassionate nurses. Fellows' List of Research Publications 2010-2018 (fellows names appear in bold), Associate Program Director Lisa X. Lee, MD, Associate Program Diorectr Ann Eapen, MD, Research Rotation Director Angela Fleischman, MD, PhD, Division Chief: Edward L. Nelson, MD, FACP, Christopher SongEducation Programs Assistant AnalystPhone: 714-456-6589Fax: 714-456-2242E-mail: csong3@uci.edu, The Division of Hematology/OncologyUCI Medical Center101 The City Drive SouthBuilding 56, Room 239, ZOT 4061Orange, CA 92868, University of California, Irvine Irvine, CA 92697, Accreditation Council for Graduate Medical Education (ACGME), American Board of Internal Medicine (ABIM), Educational Commission for Foreign Medical Graduates (ECFMG), Electronic Residency Application Service (ERAS), A novel method for demonstrating cold agglutinin disease: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905110/, Secondary hemophagocytic lymphohistiocytosis in the setting of metastatic renal cell carcinoma: a case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333406/, PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533281/, Prostatic Lymphoma Masquerading as Urinary Retention and Hematuria With Review of Literature, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650011/, http://pancreas.imedpub.com/pancreatic-neuroendocrine-tumors-therapy.pdf, Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia, https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summaryn_pr?p_JournalId=4&p_RefId=2737934, Treatment of pregnancy associated metastatic hormone and Her-2 receptor positive inflammatory breast cancer: A real challenge, https://doi.org/10.1016/j.ctarc.2016.09.003, https://www.sciencedirect.com/science/article/pii/S2468294216300739, Deadly Portland Cement: The Triad of Pulmonary, Dermatologic and Hematological Manifestations, https://www.sciencedirect.com/science/article/pii/S0002962916301379?via%3Dihub, BRAFV600E Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008024/, Primary Hepatic Osteosarcoma: A Rare Cause of Primary Liver Tumor, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827792/. She has a particular interest in benign and malignant hematology, genitourinary malignancies, and cancer prevention. He has been invited to speak at more than 50 meetings and conferences around the world, including as keynote speaker. Telephone consultation is available 24 hours a day. We are physicians and scientists committed to improving the condition of patients with cancer and blood disorders through state-of-the-art clinical care, research and education. The posted UC salary scales set the minimum pay determined by rank and/or step at appointment. Top Rated Mission Hills, CA Oncologists - Doctors & Physicians | Vitals Stefan Ciurea | UCI Health | Orange County, CA Frank Meyskens, MD Director Emeritus, Chao Family Comprehensive Cancer Center. El Segundo, CA . Our cancer specialists assess your condition and identify appropriate therapies as quickly as possible. Professor and Chair, Department of Radiation Oncology, Program Co-Leader, Biotechnology, Imaging & Drug Development, Professor, Dermatology and Biological Chemistry, Co-Chair, Protocol Review and Monitoring Committee, Associate Vice Chancellor, Clinical and Translational Science, Director, Institute for Clinical and Translational Sciences, School of Medicine Vice Dean for Clinical Science, Associate Director, Cancer Research Training & Education Coordination, Medical Director for the Stern Center for Cancer Clinical Trials & Research, Professor of Clinical Medicine, Hematology/Oncology, Director Emeritus, Chao Family Comprehensive Cancer Center, Professor of Medicine, Biological Chemistry and Public Health, School of Medicine Vice Dean for Basic Science, Professor, Chemistry and Molecular Biology and Biochemistry, Associate Vice Chancellor, Strategic Initiatives, Office of Research, Program Co-Leader, Systems, Pathways & Targets, Associate Director, Population Science & Cancer Control, Division Chief of Surgical Oncology, Department of Surgery, Co-Director of Center for Cancer Systems Biology, Senior Associate Dean & Associate Vice Chancellor for Cancer, Associate Director, Cancer Health Disparities & Community Engagement, Professor, Epidemiology, School of Public Health, Director, Genomics Research and Technology Hub (GRTH), Professor, Biomedical Engineering & Surgery, 200 S. Manchester Drive, Orange, CA 92868-3217, General Medical Appointments: 714-456-8000, Biotechnology, Imaging & Drug Development, Stern Center for Cancer Clinical Trials and Research, Acknowledgement of Grant and Shared Resources, Anti-Cancer Challenge Pilot Research Projects, CSUF/UCI-CFCCC Cancer Health Equity Research Partnership (CHERP), UCI Susan & Henry Samueli College of Health Sciences. The division's faculty members serve patients with hematologic and oncologic disorders at the medicalcenter, which is consistently listedamong the top 50 U.S. hospitals by U.S. News & World Report, as well as at the VA Long Beach Healthcare System. Application WindowOpen November 16, 2022 through Thursday, Nov 16, 2023 at 11:59pm (PacificSee this and similar jobs on LinkedIn. Uci heme onc fellows irs form 5695 for 2022 how badly do you need to pee gotoquiz. One of our goals is to help you confront any fears and develop a proactive attitude that encourages healing. For example, radiation or chemotherapy may be used to shrink a tumor before surgery. Candidates also must have a valid California medical license before beginning the fellowship program as required by state law. Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study Latest version (submitted February 28, 2023) on ClinicalTrials.gov A study version is represented by a row in the table. We work closely with you and your family to discuss potential treatment options and encourage questions. UCI Health medical oncologists are at the forefront of cancer treatment with chemotherapeutic drugs, biological agents and therapies that work with the patients immune system. Candidates must be a U.S. citizen, permanent resident orhold a J-1 visa with ECFMG sponsorshipat the time of application submission. You have access to the most advanced diagnostic and treatment technologies, including TrueBeam STx radiotherapy, a groundbreaking method of delivering powerful, targeted radiation faster and more precisely than with conventional radiotherapy. We also offer additional services, such as dietary guidance, pain management, counseling and support groups. We are recognized for providing the highest quality care by the Quality OncologyPractice Initiative (QOPI) CertificationProgram, which is an affiliate of the American Society of Clinical Oncology. We are recognized for delivering the highest quality care by the Quality OncologyPractice Initiative (QOPI) CertificationProgram, which is an affiliate of the American Society of Clinical Oncology.